This week, readers urge the government to support snooker as a sport in the city and warn against replacing professionals ...

Delhi-NCR hospitals report a 40 per cent surge in hepatitis A and E cases this monsoon. Experts warn poor sanitation, unsafe ...

Nagaland joined the global observance of World Hepatitis Day 2025 on July 28 under the theme “Hepatitis: Let’s Break It Down” ...

Timothy Allerton, PhD, is an assistant professor of vascular metabolism at Pennington Biomedical Research Center. He is a licensed clinical exercise physiologist. During his postdoctoral fellowship, ...

President Donald Trump teased the announcement last week, but Coca-Cola finally confirmed it Tuesday: a version of Coke’s ...

Roctavian zeroes out bleeds and sustains factor VIII levels for up to five years, with most patients staying off prophylaxis, ...

Replimune stock fell after the FDA rejected its RP1 application, citing flaws in the trial design and lack of substantial evidence for approval.

HANGZHOU, BEIJING, China and CAMBRIDGE, Mass., July 22, 2025 /PRNewswire/ -- METiS Technologies, a global leader in AI-driven ...

More information: Shruthi Sakthivel et al, Turn‐On Luminescent Detection of Liver Cancer Biomarker β‐Glucuronidase Using a Terbium‐Based Paper Sensor, Chemistry – An Asian Journal (2025).

Limiting carcinogen exposure or taking a statin drug could lower liver inflammation and cancer risk associated with HBV infection   ...

Liver cirrhosis can cause ascites in the liver due to the accumulation of fluid. Learn more here about ascites and liver cirrhosis here.

Researchers from Virginia Commonwealth University's (VCU) Massey Comprehensive Cancer Center have discovered a new genetic target that could possibly shape the future of treatment for liver cancer.